lance-armstrong_dopingIt seems like Greg LeMond is not alone in his crusade to expose Lance Armstrong for what he really is – a doper.

According to the news report by the Herald Sun, the famed Australian sports scientist Dr Michael Ashenden, is not happy (that’s putting it mildly) with the news that seven-time Tour de France champ is jjoining the Tour Down Under. It was Ashenden who has made analysis of Armstrong’s urine samples taken from the 1999 Tour de France, which allegedly contained the blood booster erythropoietin (EPO).

It is obvious that Ashenden is dismayed that all his hard work will be for naught.
“It surprises me that the Tour is willing to embrace such a controversial figure,” Ashenden said.

“It surprises me in the wider context that there hasn’t been more adverse reaction to his proposal to come back.”

More from the Herald Sun:

Armstrong’s camp pointed to procedural and privacy issues over the 1999 samples and no sanction was imposed, although Dr Ashenden’s findings remain the blackest marks on Armstrong’s career.

The International Cycling Union last week ruled Armstrong could take part in the Tour Down Under, despite the cyclist not complying with a six-month drug testing program in the lead-up to the January event.

“People are dazzled by the star factor and they are not pausing to really reflect on what this is all about and whether or not it would be good for the sport,” Dr Ashenden said.
He also questioned Armstrong’s motives in appointing prominent anti-doping scientist Don Catlin to his team.

“Everyone recognises that this is prone to abuse. If Don Catlin finds EPO he can’t do anything about it,” Dr Ashenden said.

The 2009 Tour Down Under will be a week-long sport spectacle to be held in January 18-25. The Tour Down Under started in 1999 and since then has been held annually in Adelaide, South Australia, and surrounding areas. This year’s overall winner is Germany’s Andre Greipel.